nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—ANPEP—bile—pancreatic cancer	0.155	0.456	CbGeAlD
Icatibant—BDKRB2—islet of Langerhans—pancreatic cancer	0.0453	0.133	CbGeAlD
Icatibant—ANPEP—gall bladder—pancreatic cancer	0.0431	0.127	CbGeAlD
Icatibant—BDKRB2—pancreas—pancreatic cancer	0.0318	0.0935	CbGeAlD
Icatibant—ANPEP—islet of Langerhans—pancreatic cancer	0.0282	0.0829	CbGeAlD
Icatibant—ANPEP—pancreas—pancreatic cancer	0.0198	0.0583	CbGeAlD
Icatibant—ANPEP—digestive system—pancreatic cancer	0.0169	0.0498	CbGeAlD
Icatibant—ANPEP—Peptide hormone metabolism—PCSK1—pancreatic cancer	0.0125	0.0194	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CCKAR—pancreatic cancer	0.00949	0.0148	CbGpPWpGaD
Icatibant—BDKRB2—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—pancreatic cancer	0.00818	0.0128	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—PRLHR—pancreatic cancer	0.0079	0.0123	CbGpPWpGaD
Icatibant—BDKRB2—Validated transcriptional targets of deltaNp63 isoforms—HES1—pancreatic cancer	0.00773	0.0121	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—NDRG1—pancreatic cancer	0.00765	0.0119	CbGpPWpGaD
Icatibant—BDKRB2—ACE Inhibitor Pathway—TGFB1—pancreatic cancer	0.00707	0.011	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—SSTR3—pancreatic cancer	0.00672	0.0105	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—GCG—pancreatic cancer	0.00655	0.0102	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—TNFRSF10B—pancreatic cancer	0.0065	0.0101	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—SSTR1—pancreatic cancer	0.00644	0.01	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—AGTR1—pancreatic cancer	0.00638	0.00995	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—PPY—pancreatic cancer	0.00632	0.00985	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—SSTR2—pancreatic cancer	0.0062	0.00967	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—PRLHR—pancreatic cancer	0.00619	0.00965	CbGpPWpGaD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—KDR—pancreatic cancer	0.00616	0.0096	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—CCKBR—pancreatic cancer	0.00607	0.00946	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCKBR—pancreatic cancer	0.00599	0.00934	CbGpPWpGaD
Icatibant—BDKRB2—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—pancreatic cancer	0.00584	0.00911	CbGpPWpGaD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—NOTCH1—pancreatic cancer	0.0058	0.00904	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—SSTR3—pancreatic cancer	0.00567	0.00884	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—TGFA—pancreatic cancer	0.00553	0.00862	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—SSTR1—pancreatic cancer	0.00543	0.00848	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—CCKBR—pancreatic cancer	0.00543	0.00846	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—PPY—pancreatic cancer	0.00533	0.00831	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—HES1—pancreatic cancer	0.00531	0.00829	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—PRLHR—pancreatic cancer	0.0053	0.00827	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—SSTR3—pancreatic cancer	0.00526	0.0082	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—SSTR2—pancreatic cancer	0.00523	0.00816	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—GAST—pancreatic cancer	0.00522	0.00814	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—SSTR1—pancreatic cancer	0.00504	0.00787	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—HSPA1B—pancreatic cancer	0.00493	0.00768	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—SSTR2—pancreatic cancer	0.00485	0.00757	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—CCK—pancreatic cancer	0.00472	0.00736	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCKBR—pancreatic cancer	0.00469	0.00731	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—pancreatic cancer	0.00467	0.00728	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCK—pancreatic cancer	0.00466	0.00726	CbGpPWpGaD
Icatibant—BDKRB2—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—pancreatic cancer	0.00464	0.00723	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—CCKAR—pancreatic cancer	0.00452	0.00705	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—SSTR3—pancreatic cancer	0.00451	0.00703	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCKAR—pancreatic cancer	0.00447	0.00696	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—GADD45A—pancreatic cancer	0.00441	0.00688	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—SSTR1—pancreatic cancer	0.00432	0.00674	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatic cancer	0.00424	0.00661	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—pancreatic cancer	0.00422	0.00658	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—SSTR2—pancreatic cancer	0.00416	0.00649	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—HSPA1A—pancreatic cancer	0.00416	0.00649	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—pancreatic cancer	0.00404	0.00631	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—PRLHR—pancreatic cancer	0.00404	0.0063	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCKBR—pancreatic cancer	0.00402	0.00627	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—FUT8—pancreatic cancer	0.00385	0.00601	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CNR2—pancreatic cancer	0.00383	0.00597	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CNR2—pancreatic cancer	0.00355	0.00554	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—SST—pancreatic cancer	0.00353	0.00551	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatic cancer	0.0035	0.00545	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—SSTR3—pancreatic cancer	0.00343	0.00535	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—SSTR1—pancreatic cancer	0.00329	0.00513	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—PPY—pancreatic cancer	0.00323	0.00503	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—GCG—pancreatic cancer	0.00319	0.00497	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—CDKN2A—pancreatic cancer	0.00319	0.00497	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—SSTR2—pancreatic cancer	0.00317	0.00494	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.00312	0.00487	CbGpPWpGaD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—TGFB1—pancreatic cancer	0.00311	0.00485	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCKBR—pancreatic cancer	0.00306	0.00477	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.00304	0.00475	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—AGTR1—pancreatic cancer	0.00304	0.00474	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—AGTR1—pancreatic cancer	0.003	0.00468	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.003	0.00467	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—PTGS2—pancreatic cancer	0.00298	0.00465	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—SST—pancreatic cancer	0.00298	0.00464	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatic cancer	0.00285	0.00444	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CNR1—pancreatic cancer	0.00275	0.00429	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—pancreatic cancer	0.00272	0.00424	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—BCL2L1—pancreatic cancer	0.00272	0.00424	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—TSC2—pancreatic cancer	0.0027	0.00421	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—CCND1—pancreatic cancer	0.00269	0.0042	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—CTNNB1—pancreatic cancer	0.00264	0.00412	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	0.00255	0.00398	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—MET—pancreatic cancer	0.00253	0.00395	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—SCT—pancreatic cancer	0.00249	0.00389	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCK—pancreatic cancer	0.00238	0.00371	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.00237	0.00369	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—PCSK1—pancreatic cancer	0.00235	0.00367	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	0.00235	0.00366	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CNR2—pancreatic cancer	0.00232	0.00362	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—GLP1R—pancreatic cancer	0.00232	0.00362	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—NRAS—pancreatic cancer	0.00232	0.00361	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCKAR—pancreatic cancer	0.00228	0.00356	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—PIK3CG—pancreatic cancer	0.00227	0.00354	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—EGF—pancreatic cancer	0.00224	0.0035	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—RB1—pancreatic cancer	0.0022	0.00344	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.00219	0.00341	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—MYC—pancreatic cancer	0.00216	0.00337	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.00215	0.00336	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—MMP2—pancreatic cancer	0.00211	0.0033	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—SHH—pancreatic cancer	0.00208	0.00324	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PRLHR—pancreatic cancer	0.00207	0.00323	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—IAPP—pancreatic cancer	0.00205	0.0032	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.00201	0.00314	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—KRAS—pancreatic cancer	0.00199	0.00311	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—PIK3CD—pancreatic cancer	0.00199	0.00311	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—PTHLH—pancreatic cancer	0.00197	0.00307	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—PTCH1—pancreatic cancer	0.00197	0.00307	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—SSTR3—pancreatic cancer	0.00194	0.00303	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GDI2—pancreatic cancer	0.0019	0.00296	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GDI1—pancreatic cancer	0.0019	0.00296	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00186	0.0029	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PPY—pancreatic cancer	0.00182	0.00284	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—SST—pancreatic cancer	0.0018	0.00281	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—SSTR2—pancreatic cancer	0.00179	0.00279	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SSTR3—pancreatic cancer	0.00176	0.00275	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—PIK3CB—pancreatic cancer	0.00174	0.00271	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00173	0.0027	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—HRAS—pancreatic cancer	0.0017	0.00264	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SSTR1—pancreatic cancer	0.00169	0.00263	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CNR1—pancreatic cancer	0.00166	0.0026	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PPY—pancreatic cancer	0.00166	0.00258	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SSTR2—pancreatic cancer	0.00163	0.00254	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—GCG—pancreatic cancer	0.00161	0.00251	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—PTEN—pancreatic cancer	0.00158	0.00246	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCKBR—pancreatic cancer	0.00157	0.00245	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—AGTR1—pancreatic cancer	0.00153	0.00239	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GAST—pancreatic cancer	0.00149	0.00232	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—SCT—pancreatic cancer	0.00141	0.0022	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL8—pancreatic cancer	0.00138	0.00214	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GAST—pancreatic cancer	0.00135	0.00211	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCK—pancreatic cancer	0.00134	0.0021	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	0.00134	0.00209	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CNR2—pancreatic cancer	0.00131	0.00204	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00131	0.00204	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.00129	0.00201	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—EGFR—pancreatic cancer	0.00128	0.002	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SCT—pancreatic cancer	0.00128	0.002	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—GCG—pancreatic cancer	0.00124	0.00193	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PRLHR—pancreatic cancer	0.00122	0.00191	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCK—pancreatic cancer	0.00122	0.0019	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	0.00122	0.0019	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CNR2—pancreatic cancer	0.00119	0.00186	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GLP1R—pancreatic cancer	0.00119	0.00186	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCKAR—pancreatic cancer	0.00117	0.00183	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IAPP—pancreatic cancer	0.00116	0.00181	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.00116	0.00181	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	0.00115	0.0018	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ACVR1B—pancreatic cancer	0.00115	0.00179	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ZNRF3—pancreatic cancer	0.00115	0.00179	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00111	0.00174	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—TP53—pancreatic cancer	0.00108	0.00168	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SHH—pancreatic cancer	0.00107	0.00166	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	0.00106	0.00165	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IAPP—pancreatic cancer	0.00105	0.00164	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DTX1—pancreatic cancer	0.00104	0.00162	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SSTR3—pancreatic cancer	0.00104	0.00162	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—SST—pancreatic cancer	0.00102	0.00159	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PTHLH—pancreatic cancer	0.00101	0.00158	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PTCH1—pancreatic cancer	0.00101	0.00158	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000999	0.00156	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SSTR1—pancreatic cancer	0.000998	0.00156	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PPY—pancreatic cancer	0.000978	0.00153	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SSTR2—pancreatic cancer	0.00096	0.0015	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CNR1—pancreatic cancer	0.00094	0.00147	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCKBR—pancreatic cancer	0.000927	0.00145	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SST—pancreatic cancer	0.000925	0.00144	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000922	0.00144	CbGpPWpGaD
Icatibant—Injection site reaction—Gemcitabine—pancreatic cancer	0.000912	0.0493	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.00091	0.00142	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GCG—pancreatic cancer	0.000908	0.00142	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000884	0.00138	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DTX4—pancreatic cancer	0.000872	0.00136	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GLI1—pancreatic cancer	0.000872	0.00136	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000866	0.00135	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.00086	0.00134	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CNR1—pancreatic cancer	0.000854	0.00133	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000848	0.00132	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NRP1—pancreatic cancer	0.000848	0.00132	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GCG—pancreatic cancer	0.000825	0.00129	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HEY2—pancreatic cancer	0.000816	0.00127	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GAST—pancreatic cancer	0.000797	0.00124	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.00079	0.00123	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000787	0.00123	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SCT—pancreatic cancer	0.000756	0.00118	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HEY1—pancreatic cancer	0.000756	0.00118	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000731	0.00114	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCK—pancreatic cancer	0.000721	0.00112	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CNR2—pancreatic cancer	0.000703	0.0011	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GLP1R—pancreatic cancer	0.000703	0.0011	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000702	0.0011	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCKAR—pancreatic cancer	0.000691	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—JAG2—pancreatic cancer	0.00067	0.00105	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MEN1—pancreatic cancer	0.000661	0.00103	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—MMP2—pancreatic cancer	0.00065	0.00101	CbGpPWpGaD
Icatibant—Injection site reaction—Docetaxel—pancreatic cancer	0.000647	0.035	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—SHH—pancreatic cancer	0.00063	0.000983	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000626	0.000977	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IAPP—pancreatic cancer	0.000623	0.000971	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTHLH—pancreatic cancer	0.000598	0.000932	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTCH1—pancreatic cancer	0.000598	0.000932	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SST—pancreatic cancer	0.000547	0.000852	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CXCL8—pancreatic cancer	0.00054	0.000843	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000539	0.000841	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—JAG1—pancreatic cancer	0.000535	0.000834	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000533	0.000831	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CNR1—pancreatic cancer	0.000504	0.000787	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CTNNB1—pancreatic cancer	0.000498	0.000777	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.00049	0.000764	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GCG—pancreatic cancer	0.000487	0.00076	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000474	0.000739	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AGTR1—pancreatic cancer	0.000465	0.000725	CbGpPWpGaD
Icatibant—Nervous system disorder—Erlotinib—pancreatic cancer	0.000462	0.025	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—STK11—pancreatic cancer	0.000458	0.000714	CbGpPWpGaD
Icatibant—Injection site reaction—Epirubicin—pancreatic cancer	0.000436	0.0236	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.00043	0.000671	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000413	0.000644	CbGpPWpGaD
Icatibant—Injection site reaction—Doxorubicin—pancreatic cancer	0.000404	0.0218	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—SMAD4—pancreatic cancer	0.000401	0.000626	CbGpPWpGaD
Icatibant—Nervous system disorder—Sunitinib—pancreatic cancer	0.0004	0.0216	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000397	0.000619	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HES1—pancreatic cancer	0.000392	0.000611	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000375	0.000585	CbGpPWpGaD
Icatibant—Body temperature increased—Erlotinib—pancreatic cancer	0.000372	0.0201	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CXCL8—pancreatic cancer	0.00036	0.000562	CbGpPWpGaD
Icatibant—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000351	0.019	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—TERT—pancreatic cancer	0.000343	0.000535	CbGpPWpGaD
Icatibant—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000336	0.0181	CcSEcCtD
Icatibant—Nervous system disorder—Irinotecan—pancreatic cancer	0.000329	0.0178	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—HIF1A—pancreatic cancer	0.000328	0.000512	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TSC2—pancreatic cancer	0.000327	0.000511	CbGpPWpGaD
Icatibant—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000327	0.0177	CcSEcCtD
Icatibant—Body temperature increased—Sunitinib—pancreatic cancer	0.000322	0.0174	CcSEcCtD
Icatibant—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000322	0.0174	CcSEcCtD
Icatibant—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000321	0.0173	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—APOE—pancreatic cancer	0.00032	0.0005	CbGpPWpGaD
Icatibant—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000316	0.017	CcSEcCtD
Icatibant—Dizziness—Tamoxifen—pancreatic cancer	0.000315	0.017	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—KDR—pancreatic cancer	0.000314	0.00049	CbGpPWpGaD
Icatibant—Dizziness—Erlotinib—pancreatic cancer	0.000312	0.0168	CcSEcCtD
Icatibant—Hypersensitivity—Sunitinib—pancreatic cancer	0.0003	0.0162	CcSEcCtD
Icatibant—Rash—Tamoxifen—pancreatic cancer	0.0003	0.0162	CcSEcCtD
Icatibant—Dermatitis—Tamoxifen—pancreatic cancer	0.0003	0.0162	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000299	0.000466	CbGpPWpGaD
Icatibant—Headache—Tamoxifen—pancreatic cancer	0.000298	0.0161	CcSEcCtD
Icatibant—Rash—Erlotinib—pancreatic cancer	0.000297	0.016	CcSEcCtD
Icatibant—Dermatitis—Erlotinib—pancreatic cancer	0.000297	0.016	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000296	0.000461	CbGpPWpGaD
Icatibant—Headache—Erlotinib—pancreatic cancer	0.000295	0.0159	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000289	0.000451	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—NRAS—pancreatic cancer	0.000289	0.000451	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EGF—pancreatic cancer	0.000286	0.000446	CbGpPWpGaD
Icatibant—Nausea—Tamoxifen—pancreatic cancer	0.000283	0.0153	CcSEcCtD
Icatibant—Nausea—Erlotinib—pancreatic cancer	0.00028	0.0151	CcSEcCtD
Icatibant—Dizziness—Sunitinib—pancreatic cancer	0.00027	0.0146	CcSEcCtD
Icatibant—Body temperature increased—Irinotecan—pancreatic cancer	0.000266	0.0143	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—EGFR—pancreatic cancer	0.000263	0.000411	CbGpPWpGaD
Icatibant—Body temperature increased—Gemcitabine—pancreatic cancer	0.000259	0.014	CcSEcCtD
Icatibant—Rash—Sunitinib—pancreatic cancer	0.000257	0.0139	CcSEcCtD
Icatibant—Dermatitis—Sunitinib—pancreatic cancer	0.000257	0.0139	CcSEcCtD
Icatibant—Headache—Sunitinib—pancreatic cancer	0.000256	0.0138	CcSEcCtD
Icatibant—Body temperature increased—Fluorouracil—pancreatic cancer	0.000254	0.0137	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000254	0.000397	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000252	0.000393	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—KRAS—pancreatic cancer	0.000249	0.000388	CbGpPWpGaD
Icatibant—Hypersensitivity—Irinotecan—pancreatic cancer	0.000248	0.0134	CcSEcCtD
Icatibant—Nausea—Sunitinib—pancreatic cancer	0.000242	0.0131	CcSEcCtD
Icatibant—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000237	0.0128	CcSEcCtD
Icatibant—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000232	0.0125	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000229	0.000357	CbGpPWpGaD
Icatibant—Nervous system disorder—Docetaxel—pancreatic cancer	0.000228	0.0123	CcSEcCtD
Icatibant—Dizziness—Irinotecan—pancreatic cancer	0.000222	0.012	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—PIK3CB—pancreatic cancer	0.000222	0.000346	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL8—pancreatic cancer	0.000213	0.000332	CbGpPWpGaD
Icatibant—Dizziness—Fluorouracil—pancreatic cancer	0.000213	0.0115	CcSEcCtD
Icatibant—Rash—Irinotecan—pancreatic cancer	0.000212	0.0114	CcSEcCtD
Icatibant—Dermatitis—Irinotecan—pancreatic cancer	0.000212	0.0114	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—HRAS—pancreatic cancer	0.000212	0.00033	CbGpPWpGaD
Icatibant—Headache—Irinotecan—pancreatic cancer	0.00021	0.0114	CcSEcCtD
Icatibant—Rash—Gemcitabine—pancreatic cancer	0.000206	0.0111	CcSEcCtD
Icatibant—Dermatitis—Gemcitabine—pancreatic cancer	0.000206	0.0111	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—AKT1—pancreatic cancer	0.000206	0.000321	CbGpPWpGaD
Icatibant—Headache—Gemcitabine—pancreatic cancer	0.000205	0.0111	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CASP3—pancreatic cancer	0.000204	0.000318	CbGpPWpGaD
Icatibant—Rash—Fluorouracil—pancreatic cancer	0.000203	0.011	CcSEcCtD
Icatibant—Dermatitis—Fluorouracil—pancreatic cancer	0.000203	0.0109	CcSEcCtD
Icatibant—Headache—Fluorouracil—pancreatic cancer	0.000202	0.0109	CcSEcCtD
Icatibant—Nausea—Irinotecan—pancreatic cancer	0.0002	0.0108	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CCND1—pancreatic cancer	0.000198	0.000309	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CTNNB1—pancreatic cancer	0.000196	0.000306	CbGpPWpGaD
Icatibant—Nausea—Gemcitabine—pancreatic cancer	0.000194	0.0105	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—MMP9—pancreatic cancer	0.000193	0.0003	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTEN—pancreatic cancer	0.000191	0.000299	CbGpPWpGaD
Icatibant—Nausea—Fluorouracil—pancreatic cancer	0.000191	0.0103	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—AKT1—pancreatic cancer	0.000187	0.000291	CbGpPWpGaD
Icatibant—Body temperature increased—Docetaxel—pancreatic cancer	0.000184	0.00992	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—SRC—pancreatic cancer	0.000178	0.000277	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VEGFA—pancreatic cancer	0.000173	0.00027	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—STAT3—pancreatic cancer	0.000171	0.000267	CbGpPWpGaD
Icatibant—Hypersensitivity—Docetaxel—pancreatic cancer	0.000171	0.00924	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—NRAS—pancreatic cancer	0.000171	0.000266	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MYC—pancreatic cancer	0.000159	0.000248	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TGFB1—pancreatic cancer	0.000159	0.000248	CbGpPWpGaD
Icatibant—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000157	0.00846	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—EGFR—pancreatic cancer	0.000156	0.000243	CbGpPWpGaD
Icatibant—Nervous system disorder—Epirubicin—pancreatic cancer	0.000154	0.0083	CcSEcCtD
Icatibant—Dizziness—Docetaxel—pancreatic cancer	0.000154	0.0083	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—KRAS—pancreatic cancer	0.000147	0.000229	CbGpPWpGaD
Icatibant—Rash—Docetaxel—pancreatic cancer	0.000146	0.00791	CcSEcCtD
Icatibant—Dermatitis—Docetaxel—pancreatic cancer	0.000146	0.0079	CcSEcCtD
Icatibant—Headache—Docetaxel—pancreatic cancer	0.000145	0.00786	CcSEcCtD
Icatibant—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000145	0.00783	CcSEcCtD
Icatibant—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000142	0.00768	CcSEcCtD
Icatibant—Nausea—Docetaxel—pancreatic cancer	0.000138	0.00745	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—PIK3CA—pancreatic cancer	0.000135	0.000211	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TP53—pancreatic cancer	0.000131	0.000204	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HRAS—pancreatic cancer	0.000125	0.000195	CbGpPWpGaD
Icatibant—Body temperature increased—Epirubicin—pancreatic cancer	0.000124	0.00669	CcSEcCtD
Icatibant—Hypersensitivity—Epirubicin—pancreatic cancer	0.000115	0.00623	CcSEcCtD
Icatibant—Body temperature increased—Doxorubicin—pancreatic cancer	0.000115	0.00619	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—AKT1—pancreatic cancer	0.00011	0.000172	CbGpPWpGaD
Icatibant—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000107	0.00577	CcSEcCtD
Icatibant—Dizziness—Epirubicin—pancreatic cancer	0.000104	0.0056	CcSEcCtD
Icatibant—Rash—Epirubicin—pancreatic cancer	9.88e-05	0.00534	CcSEcCtD
Icatibant—Dermatitis—Epirubicin—pancreatic cancer	9.87e-05	0.00533	CcSEcCtD
Icatibant—Headache—Epirubicin—pancreatic cancer	9.81e-05	0.0053	CcSEcCtD
Icatibant—Dizziness—Doxorubicin—pancreatic cancer	9.58e-05	0.00518	CcSEcCtD
Icatibant—Nausea—Epirubicin—pancreatic cancer	9.3e-05	0.00503	CcSEcCtD
Icatibant—Rash—Doxorubicin—pancreatic cancer	9.14e-05	0.00494	CcSEcCtD
Icatibant—Dermatitis—Doxorubicin—pancreatic cancer	9.13e-05	0.00493	CcSEcCtD
Icatibant—Headache—Doxorubicin—pancreatic cancer	9.08e-05	0.00491	CcSEcCtD
Icatibant—Nausea—Doxorubicin—pancreatic cancer	8.61e-05	0.00465	CcSEcCtD
